TPST logo

Tempest Therapeutics, Inc. (TPST)

Profile

Full Name

Tempest Therapeutics, Inc.

Ticker

NASDAQ: TPST

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 12, 2012

Indexes

Not included

Website

https://www.tempesttx.com

Employees

24

Key Details

Price

$9.58(-4.87%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$19.50(-920.94% YoY)

PE ratio

-

Next earnings date

Nov 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $9.58
    TPST price is $9.58

    30-Day Relative Volume

    0.51
    TPST 30-day relative volume is 0.51

    Price Performance

    Price Most recent change

    -4.87%
    TPST price was down -4.87% on Sep 17, 2025

    Price YTD change

    -11.75%
    TPST price is down -11.75% since January 1st

    Price 1-year change

    -51.2%
    TPST price is down -51.2% year-on-year

    Price 3-year change

    -67.68%
    TPST price is down -67.68% over the past 3 years

    Price Range

    Price All-time high

    $162.89K
    TPST price is currently -99.99% below its historical high of $162.89 thousand

    Price 3-year low

    $2.21
    TPST price is currently +333.48% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $35.28M
    TPST market capitalization is $35.28 million

    Market cap 3-year change

    +48.5%
    TPST market capitalization is up +48.5% over the past 3 years

    Market cap All-time high

    $58.65B
    TPST market capitalization is currently -99.94% below its historical high of $58.65 billion

    Market cap sector rank

    28.1%
    TPST market capitalization is higher than 28.1% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +89.9%
    TPST shares outstanding is up +89.9% year-on-year

    Shares Outstanding 3-Year Change

    +359.44%
    TPST shares outstanding is up +359.44% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.62
    TPST beta is 1.62

    200-day SMA

    $9.22
    TPST price is currently +3.93% above its 200-day simple moving average

    50-day SMA

    $8.66
    TPST price is currently +10.60% above its 50-day simple moving average

    RSI

    47.99
    TPST 14-day relative strength index is 47.99

    Volume

    0.51
    TPST 30-day relative volume is 0.51

    ATR

    $0.64
    TPST average true range is $0.64

    10-day Historical Volatility

    72.40%
    TPST 10-day historical volatility is 72.40%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    TPST annual revenue is $0.00

    Revenue Analysts estimate

    -
    TPST annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    TPST annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    TPST annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$19.50
    TPST annual earnings per share is -$19.50

    EPS Analysts estimate

    -$12.78
    TPST annual earnings per share is currently +52.58% higher than the consensus analysts' forecast

    EPS 1-year change

    -920.94%
    TPST annual earnings per share is down -920.94% year-on-year

    EPS Sector rank

    7.98%
    TPST annual earnings per share is higher than 7.98% of companies in Healthcare sector

    Profit

    Gross profit

    -$389.00K
    TPST annual gross profit is -$389.00 thousand

    Gross margin

    -
    TPST annual gross profit margin value is unknown

    Operating profit

    -$42.03M
    TPST annual operating income is -$42.03 million

    Operating margin

    -
    TPST annual operating profit margin value is unknown

    Net income

    -$41.84M
    TPST annual net profit is -$41.84 million

    Net margin

    -
    TPST annual net profit margin value is unknown

    Expenses

    Total expenses

    $41.84M
    TPST annual total expenses is $41.84 million

    Operating expenses

    $41.64M
    TPST annual total operating expenses is $41.64 million

    Cost of goods sold

    $389.00K
    TPST annual cost of goods sold is $389.00 thousand

    Selling, general & administrative expenses

    $0.00
    TPST annual SGA is $0.00

    Depreciation and amortization

    $389.00K
    TPST annual depreciation & amortization is $389.00 thousand

    Interest expense

    $0.00
    TPST annual interest expense is $0.00

    Income tax

    $0.00
    TPST annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$42.03M
    TPST annual earnings before interest & taxes is -$42.03 million

    EBITDA

    -$41.64M
    TPST annual EBITDA is -$41.64 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $44.02M
    TPST annual total assets is $44.02 million

    Non current assets

    $10.01M
    TPST annual long term assets is $10.01 million

    Current assets

    $31.47M
    TPST annual total current assets is $31.47 million

    Cash and cash equivalents

    $30.27M
    TPST annual cash & cash equivalents is $30.27 million

    Accounts receivable

    -
    TPST annual accounts receivable value is unknown

    Inventory

    $0.00
    TPST annual inventory is $0.00

    Liabilities

    Total liabilities

    $24.90M
    TPST annual total liabilities is $24.90 million

    Long term liabilities

    $2.54M
    TPST annual total long term liabilities is $2.54 million

    Current liabilities

    $14.22M
    TPST annual total current liabilities is $14.22 million

    Accounts payable

    $2.45M
    TPST annual accounts payable is $2.45 million

    Debt

    Total debt

    $15.37M
    TPST annual total debt is $15.37 million

    Total debt 1-year change

    -25.63%
    TPST annual total debt is down -25.63% year-on-year

    Long term debt

    $8.14M
    TPST annual long term debt is $8.14 million

    Short term debt

    $7.22M
    TPST annual short term debt is $7.22 million

    Equity & Capital

    Shareholders equity

    $19.13M
    TPST annual stockholders equity is $19.13 million

    Book value

    $19.13M
    TPST annual book value is $19.13 million

    Retained earnings

    -$207.11M
    TPST annual retained earnings is -$207.11 million

    Working capital

    $17.25M
    TPST annual working capital is $17.25 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$33.03M
    TPST annual cash flow from operations is -$33.03 million

    Cash from operations 1-year change

    -20.73%
    TPST annual cash flow from operations is down -20.73% year-on-year

    Cash from investing

    -$435.00K
    TPST annual cash flow from investing activities is -$435.00 thousand

    Cash from investing 1-year change

    -155.88%
    TPST annual cash flow from investing activities is down -155.88% year-on-year

    Cash from financing

    $24.50M
    TPST annual cash flow from financing activities is $24.50 million

    Cash from financing 1-year change

    -31.18%
    TPST annual cash flow from financing activities is down -31.18% year-on-year

    CAPEX

    CAPEX

    $435.00K
    TPST annual capital expenditures is $435.00 thousand

    CAPEX 1-year change

    +155.88%
    TPST annual capital expenditures is up +155.88% year-on-year

    Free Cash Flow

    Free cash flow

    -$33.46M
    TPST annual free cash flow is -$33.46 million

    Free cash flow 1-year change

    -21.56%
    TPST annual free cash flow is down -21.56% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    TPST annual gross profit margin value is unknown

    Operating margin

    -
    TPST annual operating profit margin value is unknown

    Net margin

    -
    TPST annual net profit margin value is unknown

    ROA & ROE

    ROA

    -87.51%
    TPST annual return on assets is -87.51%

    ROE

    -182.35%
    TPST annual return on equity is -182.35%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TPST price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TPST price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.61
    TPST price to book ratio is 3.61

    PB ratio Sector rank

    70.56%
    TPST price to book ratio is higher than 70.56% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    TPST price to sales ratio value is unknown

    PS ratio Sector rank

    -
    TPST price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $29.66M
    TPST enterprise value is $29.66 million

    Enterprise value Sector rank

    32.23%
    TPST enterprise value is higher than 32.23% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.69
    TPST EV/EBITDA is -0.69

    EV/EBITDA Sector rank

    50.67%
    TPST EV/EBITDA is higher than 50.67% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.21
    TPST annual current ratio is 2.21

    Quick ratio

    2.21
    TPST annual quick ratio is 2.21

    Leverage

    Debt to equity

    0.80
    TPST annual debt to equity ratio is 0.80

    Interest coverage ratio

    -
    TPST annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    TPST piotroski f-score value is unknown

    Altman Z-Score

    -8.42
    TPST altman z-score is -8.42

    Analyst ratings

    Recent major analysts updates

    Apr 10, 25 Scotiabank
    Sector Perform
    Apr 10, 25 HC Wainwright & Co.
    Neutral
    Mar 28, 25 Scotiabank
    Sector Outperform
    Mar 28, 25 HC Wainwright & Co.
    Buy
    Nov 13, 24 Piper Sandler
    Overweight
    Nov 13, 24 HC Wainwright & Co.
    Buy
    Oct 10, 24 HC Wainwright & Co.
    Buy
    Aug 15, 24 HC Wainwright & Co.
    Buy
    Jun 21, 24 Piper Sandler
    Overweight
    Jun 20, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with TPST included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Tempest Therapeutics, Inc.?
    • Does Tempest Therapeutics, Inc. pay dividends?
    • What sector is Tempest Therapeutics, Inc. in?
    • What industry is Tempest Therapeutics, Inc. in?
    • What country is Tempest Therapeutics, Inc. based in?
    • When did Tempest Therapeutics, Inc. go public?
    • Is Tempest Therapeutics, Inc. in the S&P 500?
    • Is Tempest Therapeutics, Inc. in the NASDAQ 100?
    • Is Tempest Therapeutics, Inc. in the Dow Jones?
    • When was Tempest Therapeutics, Inc.'s last earnings report?
    • When does Tempest Therapeutics, Inc. report earnings?

    What is the ticker symbol for Tempest Therapeutics, Inc.?

    The ticker symbol for Tempest Therapeutics, Inc. is NASDAQ:TPST

    Does Tempest Therapeutics, Inc. pay dividends?

    No, Tempest Therapeutics, Inc. does not pay dividends

    What sector is Tempest Therapeutics, Inc. in?

    Tempest Therapeutics, Inc. is in the Healthcare sector

    What industry is Tempest Therapeutics, Inc. in?

    Tempest Therapeutics, Inc. is in the Biotechnology industry

    What country is Tempest Therapeutics, Inc. based in?

    Tempest Therapeutics, Inc. is headquartered in United States

    When did Tempest Therapeutics, Inc. go public?

    Tempest Therapeutics, Inc.'s initial public offering (IPO) was on November 12, 2012

    Is Tempest Therapeutics, Inc. in the S&P 500?

    No, Tempest Therapeutics, Inc. is not included in the S&P 500 index

    Is Tempest Therapeutics, Inc. in the NASDAQ 100?

    No, Tempest Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Tempest Therapeutics, Inc. in the Dow Jones?

    No, Tempest Therapeutics, Inc. is not included in the Dow Jones index

    When was Tempest Therapeutics, Inc.'s last earnings report?

    Tempest Therapeutics, Inc.'s most recent earnings report was on August 11, 2025

    When does Tempest Therapeutics, Inc. report earnings?

    The next expected earnings date for Tempest Therapeutics, Inc. is November 12, 2025
    On this page